29 related articles for article (PubMed ID: 27103086)
1. Rs4862705 in the melatonin receptor 1A gene is associated with renal function decline in type 1 diabetes individuals.
Daher G; Santos-Bezerra DP; Cavaleiro AM; Pelaes TS; Admoni SN; Perez RV; Machado CG; do Amaral FG; Cipolla-Neto J; Correa-Giannella ML
Front Endocrinol (Lausanne); 2024; 15():1331012. PubMed ID: 38549765
[TBL] [Abstract][Full Text] [Related]
2. Genetic Factors Associated with the Development of Neuropathy in Type 2 Diabetes.
Tordai DZ; Hajdú N; Rácz R; Istenes I; Békeffy M; Vági OE; Kempler M; Körei AE; Tóbiás B; Illés A; Pikó H; Kósa JP; Árvai K; Papp M; Lakatos PA; Kempler P; Putz Z
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339094
[TBL] [Abstract][Full Text] [Related]
3. Advantages of omics approaches for elucidating metabolic changes in diabetic peripheral neuropathy.
Yako H; Niimi N; Takaku S; Sango K
Front Endocrinol (Lausanne); 2023; 14():1208441. PubMed ID: 38089620
[TBL] [Abstract][Full Text] [Related]
4. BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy.
Bönhof GJ; Sipola G; Strom A; Herder C; Strassburger K; Knebel B; Reule C; Wollmann JC; Icks A; Al-Hasani H; Roden M; Kuss O; Ziegler D
BMJ Open; 2022 Feb; 12(2):e057142. PubMed ID: 35115359
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy.
Bojkova D; Costa R; Reus P; Bechtel M; Jaboreck MC; Olmer R; Martin U; Ciesek S; Michaelis M; Cinatl J
Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677415
[TBL] [Abstract][Full Text] [Related]
6. What Is in the Field for Genetics and Epigenetics of Diabetic Neuropathy: The Role of MicroRNAs.
Spallone V; Ciccacci C; Latini A; Borgiani P
J Diabetes Res; 2021; 2021():5593608. PubMed ID: 34660810
[TBL] [Abstract][Full Text] [Related]
7. The Role of Biofactors in Diabetic Microvascular Complications.
Ziegler D; Porta M; Papanas N; Mota M; Jermendy G; Beltramo E; Mazzeo A; Caccioppo A; Striglia E; Serhiyenko V; Serhiyenko A; Rosta L; Stirban OA; Putz Z; Istenes I; Horváth V; Kempler P
Curr Diabetes Rev; 2022; 18(4):e250821195830. PubMed ID: 34433401
[TBL] [Abstract][Full Text] [Related]
8. Effect of sugar metabolite methylglyoxal on equine lamellar explants: An ex vivo model of laminitis.
Vercelli C; Tursi M; Miretti S; Giusto G; Gandini M; Re G; Valle E
PLoS One; 2021; 16(7):e0253840. PubMed ID: 34314429
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and Molecular Treatment Strategies of Diabetic Neuropathy Collateral Glucose-Utilizing Pathways in Diabetic Polyneuropathy.
Mizukami H; Osonoi S
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374137
[TBL] [Abstract][Full Text] [Related]
10. Current concepts in the management of diabetic polyneuropathy.
Ziegler D; Papanas N; Schnell O; Nguyen BDT; Nguyen KT; Kulkantrakorn K; Deerochanawong C
J Diabetes Investig; 2021 Apr; 12(4):464-475. PubMed ID: 32918837
[TBL] [Abstract][Full Text] [Related]
11. Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.
Sergi D; Renaud J; Simola N; Martinoli MG
Front Aging Neurosci; 2019; 11():302. PubMed ID: 31787891
[TBL] [Abstract][Full Text] [Related]
12. Single cell transcriptomics based-MacSpectrum reveals novel macrophage activation signatures in diseases.
Li C; Menoret A; Farragher C; Ouyang Z; Bonin C; Holvoet P; Vella AT; Zhou B
JCI Insight; 2019 Apr; 5(10):. PubMed ID: 30990466
[TBL] [Abstract][Full Text] [Related]
13. Association of transketolase polymorphisms with measures of polyneuropathy in patients with recently diagnosed diabetes.
Ziegler D; Schleicher E; Strom A; Knebel B; Fleming T; Nawroth P; Häring HU; Papanas N; Szendrödi J; Müssig K; Al-Hasani H; Roden M;
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 27103086
[TBL] [Abstract][Full Text] [Related]
14. Might genetics play a role in understanding and treating diabetic polyneuropathy?
Spallone V
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032668
[TBL] [Abstract][Full Text] [Related]
15. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy.
Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
Diabetes Metab Syndr; 2014; 8(1):48-52. PubMed ID: 24661759
[TBL] [Abstract][Full Text] [Related]
16. Association of type 2 diabetes susceptibility loci with peripheral nerve function in a Chinese population with diabetes.
Lu J; Luo Y; Wang J; Hu C; Zhang R; Wang C; Jia W
J Diabetes Investig; 2017 Jan; 8(1):115-120. PubMed ID: 27253191
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability in enzymes of metabolic pathways conferring protection against non-enzymatic glycation versus diabetes-related morbidity and mortality.
Tanhäuserová V; Kuricová K; Pácal L; Bartáková V; Rehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
Clin Chem Lab Med; 2014 Jan; 52(1):77-83. PubMed ID: 23492569
[TBL] [Abstract][Full Text] [Related]
18. Genetic Polymorphisms of Antioxidant and Antiglycation Enzymes and Diabetic Complications. How Much Can we Learn from the Genes?
Oikonomou D; Groener JB; Cheko R; Kender Z; Kihm L; Fleming T; Kopf S; Nawroth PP
Exp Clin Endocrinol Diabetes; 2018 Jan; 126(1):7-13. PubMed ID: 28444665
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
